ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Cabana Target Leading Sector Conservative ETF

Cabana Target Leading Sector Conservative ETF (CLSC)

19.275
0.00
( 0.00% )
更新日時: 09:00:00

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
19.275
買値
14.32
売値
30.83
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
19.275
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

CLSC 最新ニュース

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

IRVINE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC) (BULLETIN BOARD: CLSC) , a pharmaceutical development company specializing in anti-allergy medications, announced today...

Cobalis Corp. PreHistin(TM) Approval Process to Be Conducted by OTC Division of FDA

FDA's Office of Nonprescription Products Will Now Handle Marketing Approval Process for Anti-Allergy Drug PreHistin(TM) IRVINE, Calif., Jan. 19 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC...

Cobalis Corp. Adds CFO to Management Team

Thomas Stankovich, Former Vice President and Chief Financial Officer of MP Biomedicals, Ribapharm and ICN / Valeant Pharmaceuticals Joins Cobalis Corp. as Chief Financial Officer IRVINE, Calif...

Cobalis Corp. PreHistin(TM) to Be Granted European Union Patent

European Patent Office Allows New Patent for PreHistin(TM) -- 'Cyanocobalamin Treatment in Allergic Disease' IRVINE, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC) (BULLETIN...

Cobalis Corp. PreHistin(TM) Significantly Reduces Allergy Symptoms in 714 Patient Phase 3 Clinical Trial

Safe, Non-Drowsy PreHistin(TM) Achieves Clinical and Statistical Significance (p= 0.0028) Versus Placebo; Study Demonstrates Dramatic Reduction in Allergy Symptoms IRVINE, Calif., Oct. 27...

Legal Opinion Reinforces Cobalis Patent

IRVINE, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC) (BULLETIN BOARD: CLSC) , a pharmaceutical biotech company specializing in the development of anti-allergy medications...

Cobalis Corp. Phase III Trial for PreHistin(TM) Shows Positive Results for Pre-Seasonal Treatment to Mitigate Allergy Symptoms i

Cobalis Corp. Phase III Trial for PreHistin(TM) Shows Positive Results for Pre-Seasonal Treatment to Mitigate Allergy Symptoms in Humans IRVINE, Calif., July 20 /PRNewswire-FirstCall/ -- Cobalis...

Nasdaq Notifies Cobalis That It Will Remove 'V' From Its Stock Symbol -- an Update on Mandatory Share Certificate Exchange

Nasdaq Notifies Cobalis That It Will Remove 'V' From Its Stock Symbol -- an Update on Mandatory Share Certificate Exchange IRVINE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC...

Cobalis Changes Its Trading Symbol From "CBSC" to "CLSC" - Update on Mandatory Share Certificate Exchange

Cobalis Changes Its Trading Symbol From "CBSC" to "CLSC" - Update on Mandatory Share Certificate Exchange IRVINE, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CBSC) (BULLETIN...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NXUNXU Inc
US$ 2.05
(742.24%)
454.64M
WATTEnergous Corporation
US$ 1.4514
(252.97%)
167.21M
INTZIntrusion Inc
US$ 5.522
(155.65%)
116.05M
JDZGJIADE Ltd
US$ 1.43
(104.23%)
5.75M
CYNCYNGN Inc
US$ 1.17
(86.34%)
61.57M
ABPAbpro Holdings Inc
US$ 2.1874
(-51.28%)
1.47M
TRAWTraws Pharma Inc
US$ 7.60
(-43.37%)
905.47k
SHOTWSafety Shot Inc
US$ 0.122005
(-32.33%)
1.1k
LITMSnow Lake Resources Ltd
US$ 1.125
(-29.69%)
45.23M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 66.74
(-24.56%)
8.99k
NXUNXU Inc
US$ 2.05
(742.24%)
454.64M
VINCVincerx Inc
US$ 0.332999
(71.65%)
303.66M
XTIAXTI Aerospace Inc
US$ 0.0399
(1.01%)
186.41M
WATTEnergous Corporation
US$ 1.4514
(252.97%)
167.21M
SMXSMX Security Matters Public Company
US$ 0.6088
(72.17%)
140.78M

最近閲覧した銘柄

Delayed Upgrade Clock